Sunniva (XCNQ:SNN) Price-to-Operating-Cash-Flow : (As of Jun. 20, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Sunniva Price-to-Operating-Cash-Flow?

As of today (2024-06-20), Sunniva's share price is C$0.155. Sunniva's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 was C$-0.73. Hence, Sunniva's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Sunniva's Price-to-Operating-Cash-Flow or its related term are showing as below:

XCNQ:SNN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 15.95
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Sunniva's Cash Flow from Operations per share for the three months ended in Sep. 2019 was C$-0.14. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 was C$-0.73.

Sunniva Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sunniva's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Price-to-Operating-Cash-Flow Chart

Sunniva Annual Data

Trend

Dec16

Dec17

Dec18

Price-to-Operating-Cash-Flow

Sunniva Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of Sunniva's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Sunniva's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunniva's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunniva's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sunniva's Price-to-Operating-Cash-Flow falls into.

Sunniva Price-to-Operating-Cash-Flow Calculation

Sunniva's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.155	/	-0.734
	=

Sunniva's Share Price of today is C$0.155.
Sunniva's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.73.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Sunniva Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sunniva's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunniva (XCNQ:SNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2

Website

https://www.sunniva.com

Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.

Executives

Mark Hamish Kimmins

Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)